Value
9.1/10data confidence 50%| Component | Sub-score |
|---|---|
| P/S | 8.2 |
| Fwd P/E | 9.3 |
| PEG | 10.0 |
- ▸Forward P/E: 10.2x
- ▸PEG: 0.03
- ▸Attractively valued
ARDX · Why this verdict
Why Ardelyx (ARDX) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score6.0/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Business quality scores at 3.9, sitting just below the 4.0 floor, which constrains position sizing to an avoid recommendation despite strong value and growth characteristics. Warnings | Quality score recovers above 4.5 for two consecutive quarters, enabling a meaningful position. | →Stable |
| CounterThe quality shortfall may be structural: free cash flow margin is 0%, FCF yield is 0.0%, and the FCF quality component scores 3.0 out of 10, suggesting limited near-term recovery in cash-generation quality. | ||
At a forward P/E of 11.0x and PEG of 0.04, the stock trades at an attractive valuation with roughly 21-to-1 in favorable risk/reward and 150% upside to the analyst price target of $14.21. Price targets | The stock closes above $10.00 within 12 months, capturing a meaningful portion of the upside toward the $14.21 target. | →Stable |
| CounterAnalyst coverage is light with a dampened signal, and the options market max pain at $13.00 sits well above the current trading price — a gap that may require a significant catalyst to close. | ||
Revenue is expanding at 28% year-over-year, a pace that, if sustained, would allow the company to grow into its already undemanding valuation without requiring multiple expansion. Growth | Revenue growth sustains above 10% year-over-year for the next two reported quarters. | →Stable |
| CounterThe growth signal carries low confidence, suggesting the underlying revenue trend may be based on limited data; only one confirmed earnings beat and two quarters with unknown results make the growth trajectory difficult to verify independently. | ||
The stock has dipped below its 200-day moving average, but the average itself is still rising at 2.6% per 30 days and volume accumulation via rising OBV suggests this is a consolidation within an ongoing uptrend rather than a confirmed breakdown. Momentum | The stock recaptures its 200-day moving average and OBV continues trending higher over the next two quarters. | →Stable |
| CounterMomentum at 4.7 remains below the 5.5 strong threshold, RSI and MACD components are both soft, and a 10% short interest in the float could intensify selling pressure if the uptrend interpretation proves incorrect. | ||
Business quality scores at 3.9, sitting just below the 4.0 floor, which constrains position sizing to an avoid recommendation despite strong value and growth characteristics.
→StableWarnings
- Expectation
- Quality score recovers above 4.5 for two consecutive quarters, enabling a meaningful position.
CounterThe quality shortfall may be structural: free cash flow margin is 0%, FCF yield is 0.0%, and the FCF quality component scores 3.0 out of 10, suggesting limited near-term recovery in cash-generation quality.
At a forward P/E of 11.0x and PEG of 0.04, the stock trades at an attractive valuation with roughly 21-to-1 in favorable risk/reward and 150% upside to the analyst price target of $14.21.
→StablePrice targets
- Expectation
- The stock closes above $10.00 within 12 months, capturing a meaningful portion of the upside toward the $14.21 target.
CounterAnalyst coverage is light with a dampened signal, and the options market max pain at $13.00 sits well above the current trading price — a gap that may require a significant catalyst to close.
Revenue is expanding at 28% year-over-year, a pace that, if sustained, would allow the company to grow into its already undemanding valuation without requiring multiple expansion.
→StableGrowth
- Expectation
- Revenue growth sustains above 10% year-over-year for the next two reported quarters.
CounterThe growth signal carries low confidence, suggesting the underlying revenue trend may be based on limited data; only one confirmed earnings beat and two quarters with unknown results make the growth trajectory difficult to verify independently.
The stock has dipped below its 200-day moving average, but the average itself is still rising at 2.6% per 30 days and volume accumulation via rising OBV suggests this is a consolidation within an ongoing uptrend rather than a confirmed breakdown.
→StableMomentum
- Expectation
- The stock recaptures its 200-day moving average and OBV continues trending higher over the next two quarters.
CounterMomentum at 4.7 remains below the 5.5 strong threshold, RSI and MACD components are both soft, and a 10% short interest in the float could intensify selling pressure if the uptrend interpretation proves incorrect.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Ardelyx offers 28% revenue growth and a forward P/E of 11.0x with roughly 21-to-1 favorable risk/reward and 150% upside to analyst targets, yet business quality sitting just below the minimum floor constrains the position recommendation to avoid until quality metrics recover.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 10.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 9.5 |
| FCF quality | 3.0 |
| Moat | 5.8 |
| Rule of 40 | 5.5 |
| Piotroski F | 5.6 |
- ▸FCF-positive despite GAAP loss (FCF margin 0%, FCF yield 0.0%)
Growth
9.4/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 9.4 |
- ▸Strong growth: 28% YoY
Momentum
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 2.7 |
| OBV | 1.0 |
| MA position | 1.5 |
| Volume | 1.1 |
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA, MA slope flat
Sentiment
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 8.2 |
| Price target | 10.0 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (10.0) — signal dampened
- ▸Analyst upside: 209%
Insider
3.4/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Notable insider selling — $1,791,342 (0.138% of mkt cap)
Peer rank
4.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 8.9 |
| quality rank | 3.8 |
| growth rank | 5.9 |
Technical
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 7.9 |
| support resistance | 7.8 |
| 52w position | 2.5 |
Risk (lower is worse)
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 4.4 |
| days to cover | 0.9 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 0.0 |
| beta | 9.4 |
| debt equity | 3.8 |
- ▸High IV: 102%
Catalyst
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 7.1 |
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (6)
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:31d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:2.0<4.5
- DEATH_CROSS:HARD_BLOCK
Warning (1)
- ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
12.5%
Sizing output
AVOID
SetupFalling Knife — Death cross, below all MAs, RSI 39, MACD bearish
EdgeInst Constrain — Small cap ($1.3B) below institutional reach
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 9.4 could not lift the engine output above the verdict floor. Failed gate signal: MOMENTUM:2.0<4.5.
The strongest dimensions are Growth at 9.4, Value at 9.1, and Sentiment at 7.9; the weakest are Momentum at 2.0, Insider at 3.4, and Quality at 3.9. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Quality Below Minimum Floor
Trip ifQuality score rises above 4.5 for 2 consecutive quarters, removing the below-floor constraint.
- P2Compelling Valuation Outsized Asymmetry
Trip ifStock price exceeds $12.00, reducing upside to the $14.21 target below 20%.
- P3Strong Revenue Growth Trajectory
Trip ifRevenue growth falls below 10% YoY for 2 consecutive quarters.
- P4Pullback Within Rising Uptrend
Trip if200-day moving average slope turns negative (below 0%) for 2 consecutive months.